| Address: | 148 Miramonte Rd, Walnut Creek, CA 94597, USA |
|---|---|
| Postal code: | 94597 |
| Phone: | (925) 280-7662 |
There are no reviews yet!
You can review this Business and help others by leaving a comment. If you want to share your thoughts about Senia Investments, use the form below and your opinion, advice or comment will appear in this space.
Senia Investments is located in Lafayette, CA and can be reached at: 925-280-7662. Get more information on Senia Investments by viewing our in-depth profile. Check it out Today!
About Senia Investments is located at the address 148 Miramonte Rd in Walnut Creek, California 94597. They can be contacted via phone at (925) 280-7662 for pricing, hours and directions.
Senia Investments in Walnut Creek, reviews by real people. Yelp is a fun and easy way to find, recommend and talk about what's great and not so great in Walnut Creek and beyond.
Senia Investments 148 Miramonte Rd Walnut Creek CA 94597. Reviews (925) 280-7662. Menu & Reservations Make Reservations . Order Online Tickets ...
Get reviews, hours, directions, coupons and more for Senia Investments at 148 Miramonte Rd, Walnut Creek, CA. Search for other Financial Planning Consultants in Walnut Creek on YP.com.
Senia Investments is located at 148 Miramonte Rd in Walnut Creek and has been in the business of Buying Agent, Real Estate since 2004.
Free Business profile for SENIA INVESTMENTS at 148 Miramonte Rd, Walnut Creek, CA, 94597-3456, US, SENIA INVESTMENTS specializes in: Investors, N.E.C.. This business can be reached at (925) 280-7662.
SENIA INVESTMENTS . Attention This business has no ratings or reviews. Join to ... (925) 280-7662. Address. 148 MIRAMONTE RD Walnut Creek, CA 94597. Map.
About Senia Investments: Senia Investments is located at 148 Miramonte Rd in Walnut Creek, CA - Contra Costa County and is a business listed in the categories Real Estate Buyer Consultants and Real Estate Consultants & Research Services.
Description: Senhwa Biosciences, Inc. (Senhwa) is a drug development company. It is engaged in development of small molecule drugs for treating newly validated targets in cancer pathways. It is engaged in development of small molecule drugs for treating newly validated targets in cancer pathways.